NEU 2.81% $18.65 neuren pharmaceuticals limited

retts syndrome, page-30

  1. 2,647 Posts.
    lightbulb Created with Sketch. 432
    wizza, thanks for the clarification, it's clear that I misread you and our opinions are actually quite close.

    POS, that was a timely reminder. Thanks for that. I think one of the key outcomes which has come to us direct from the company (as opposed to through social media) is that there have been no adverse effects or dropouts from the trial so far.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.